Wed, Sep 17, 2014, 11:11 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • phactsarephun phactsarephun Nov 15, 2012 2:18 PM Flag

    margin selling creating excellent buying opportunity

    Mr. Cavalli, would you care to now revise your previous statements about 3 drugs being approved in the US in 2013, in light of the fact that not one of the three has even started the necessary pivotal trials yet?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Ha! Good luck with getting a reply to that one Phacts.

      I am sorry to see AMPE languishing in the low $3's, but in my opinion, Robert's one-man propaganda army has not done anything for the company he wanted to work for. I suppose I should temper that thought by saying that at least he does bang the AMPE drum, so props for that. Nobody else out there seems to care one way or the other.

      By the way Robert, how did the job application work out for you? Serious question, did you get the gig?

      I was long, but sold some months ago. However, I would love to see their approach to re-purposing pre-approved drugs work out for them - really.

      I watch AMPE every day (from a long perspective) and will be back in like a shot when there is something solid or upbeat analyst indicators to support that investment.

      Have to say though, that low $3's looks like a buy all day long right now. Not too long to wait until the shareholders meeting on Saturday December 15th. Positive news there and $3's will seem to have been an early Christmas present.

 
AMPE
3.60-0.05(-1.37%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.